FXR: the key to benefits in bariatric surgery? (Q35142008)

6 August 2017

title

FXR: the key to benefits in bariatric surgery? (English)

1 reference

6 August 2017

0 references

2

Albert K Groen

1 reference

6 August 2017

Folkert Kuipers

1

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 April 2014

1 reference

6 August 2017

1 reference

6 August 2017

volume

20

1 reference

6 August 2017

issue

4

1 reference

6 August 2017

page(s)

337-338

1 reference

Long-term drug treatment for obesity: a systematic and clinical review

6 August 2017

cites work

1 reference

Bariatric surgery versus intensive medical therapy in obese patients with diabetes

21 January 2018

1 reference

Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study.

21 January 2018

1 reference

Role of bile acids and bile acid receptors in metabolic regulation

21 January 2018

1 reference

Bile salt biotransformations by human intestinal bacteria

21 January 2018

1 reference

Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism

21 January 2018

1 reference

Weight loss induced by Roux-en-Y gastric bypass but not laparoscopic adjustable gastric banding increases circulating bile acids.

21 January 2018

1 reference

Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis.

21 January 2018

1 reference

Enterohepatic circulation of bile salts in farnesoid X receptor-deficient mice: efficient intestinal bile salt absorption in the absence of ileal bile acid-binding protein

21 January 2018

1 reference

The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice

21 January 2018

1 reference

Loss of FXR protects against diet-induced obesity and accelerates liver carcinogenesis in ob/ob mice

21 January 2018

1 reference

Farnesoid X receptor deficiency improves glucose homeostasis in mouse models of obesity

21 January 2018

1 reference

FXR-deficiency confers increased susceptibility to torpor.

21 January 2018

1 reference

Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women

21 January 2018

1 reference

Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24710375

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

FXR is a molecular target for the effects of vertical sleeve gastrectomy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24710375

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NM.3525

1 reference

6 August 2017

1 reference